Parasitical Pharmaceuticals 2

Martin Shkreli, CPP - Chief Predatory Parasite

I omitted part of the Logic Of The Parasite in my first post on parasite pharmaceuticals: http://fatherdaughtertalk.blogspot.com/2016/02/economic-idiocy-from-new-yorker.html

We already mentioned that a type-2 drug company is a parasite interested only in maintaining control of a drug and a group of hosts to sell the drug to, then the drugs of interest and under the control of the type-2 drug company will not cure a disease - at least, not quickly.

If the drugs wrought miraculous cures, the group of hosts would disappear and the type-2 drug company along with them.

Further, since the type-2 parasite drug company buys from a type-1 drug company (which type-1 company is a classical research, test, and market drug company)a drug  Rx1  intended for certain range of manifestations or aspects of a certain disease   Dx1,

     then

it follows that since the type-2 drug company is not a research nor testing company, the probability that further drug research will occur in the near future for treating problems of the disease  Dx1  is very, very low; the original type-1 drug company is probably not going to do more research in that disease for a while, since it was getting rid of the drugs it developed already for that disease.

Hence, the group of hosts - the sufferers, if you will - are being condemned by our Economic System to (1) being subjects of predatory drug companies, and (2) being beyond the hope of near-term research into their disease.

This is not Economics.

This is Particular Genocide of the suffering.

As such, it should be outlawed.

--
note:
perhaps mr. shkreli called the lawmakers "imbeciles" since they could not discern this obvious fact.